Atai Life Sciences N.V.
(NQ:
ATAI
)
1.420
-0.130 (-8.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atai Life Sciences N.V.
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
New Psychedelic Drug Stock To Debut After Upsized IPO Prices At High End
June 18, 2021
Atai Life Sciences, a backer of psychedelic-drug developers, will start trading Friday, after an upsized offering for the Atai IPO.
Via
Investor's Business Daily
Topics
Initial Public Offering
Exposures
Securities Market
Is ATAI Stock A Buy After The IPO?
June 16, 2021
ATAI Life Sciences will go public this week. And investors wanting to cash in on one of the hottest medicine and mental health trends need to pay attention to this stock.
Via
Talk Markets
IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings
June 14, 2021
This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Peter Thiel-Backed Psychedelic Firm Atai Sets Terms For US IPO, Sees $2.3B Valuation
June 11, 2021
Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, has announced terms for its initial public offer...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.